Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Most Viewed Articles
1234567891011121314151617181920212223
Next »

Pfizer Opens Online Pharmacy to Fight Counterfeit Medicine

May 6, 2013

Pfizer has launched a prescription-fulfillment website for Viagra tablets in an effort to combat the online sale of counterfeited medicine.

GSK Announces Plans to Share Clinical Trial Data

May 9, 2013
By: Adeline Siew, PhD

In its commitment to transparency, GlaxoSmithKline (GSK) has outlined plans to share detailed data from its clinical trials. GSK is to establish a new online system that will enable researchers to request access to anonymised patient level data.

FDA Will Not Approve Generics to Original OxyContin

April 17, 2013
By: Rita Peters

The FDA approved updated labeling for Purdue Pharma L.P.?s reformulated OxyContin tablets, but also determined that it will not approve generic versions of the original OxyContin.

The New Normal In Biotech Financing

May 3, 2013
By: Patricia Van Arnum
PTSM: Pharmaceutical Technology Sourcing and Management

Financing to biotech companies in North American and Europe declined in 2012 as debt funding decreased and the IPO market remained weak.

Big Pharma's Manufacturing Investments in Biologics

May 1, 2013
By: Patricia Van Arnum
Pharmaceutical Technology

Despite overall manufacturing rationalization in the pharmaceutical/biopharmaceutical industry, the large pharmaceutical companies continue to invest in biologic-based manufacturing. The author provides an update in recent investment activity among the pharmaceutical majors in biologic-drug substance, vaccine, and parenteral drug manufacturing.

Pharmaceutical Technology and D&B Launch Business Marketplace

April 26, 2013

Pharmaceutical Technology has joined with Dun & Bradstreet Credibility Corp. to launch the Pharmaceutical Technology and BioPharm International Marketplace.

Big Biotech Outpaces Big Pharma, Burrill Reports

April 17, 2013

Big Biotech companies are demonstrating they are better positioned than their pharmaceutical industry counterparts to meet changing demands.

Amgen to Pay $24.9 Million for False Claims Act Violations

April 16, 2013

Amgen Inc. has agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act.

Thermo Fisher Scientific to Acquire Life Technologies

April 16, 2013

$13.6 billion deal strengthens Thermo?s leading role.

1234567891011121314151617181920212223
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here